RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

Regulatory Focus™ > News Articles > Quality & Compliance: Update on the Australian Regulatory Landscape

Quality & Compliance: Update on the Australian Regulatory Landscape

Posted 01 July 2011 | By Valentina Theisz, MSc, RAC, FRAPS

In the past, when asked about their experience with registering medical devices in Australia, most overseas regulatory professionals used to say that the process was lengthy and painful, and the local regulator, the Therapeutic Goods Administration (TGA), lacked transparency or was unresponsive. In recent years however, TGA has undergone dramatic changes.

Regulatory Focus newsletters

All the biggest regulatory news and happenings.

Subscribe

Regulatory Focus™ is doing essential, non-biased journalism during this unprecedented time. We appreciate your support as we bring you the news and intelligence you need to make an impact on global healthcare.

Regulatory Focus™ provides the intelligence you need to impact global healthcare during this crisis. Thank you for your support.